Christopher C T Sng
Overview
Explore the profile of Christopher C T Sng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sng C, Kallor A, Simpson B, Bedran G, Alfaro J, Litchfield K
Front Immunol
. 2024 Apr;
15:1347542.
PMID: 38558815
Background: Neoantigens, mutated tumour-specific antigens, are key targets of anti-tumour immunity during checkpoint inhibitor (CPI) treatment. Their identification is fundamental to designing neoantigen-directed therapy. Non-canonical neoantigens arising from the untranslated...
2.
Pinato D, Ferrante D, Aguilar-Company J, Bower M, Salazar R, Mirallas O, et al.
Eur J Cancer
. 2022 Jun;
171:64-74.
PMID: 35704976
Background: Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in this specific population is undefined. Methods: Capitalizing on...
3.
Wong Y, Sng C, Ottaviani D, Patel G, Chowdhury A, Earnshaw I, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885194
An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients with solid cancer comparing the first...
4.
Pinato D, Scotti L, Gennari A, Colomba-Blameble E, Dolly S, Loizidou A, et al.
Eur J Cancer
. 2021 May;
150:190-202.
PMID: 33932726
Background: Despite high contagiousness and rapid spread, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected nations. Within Europe (EU), the United Kingdom (UK) is...
5.
Dettorre G, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, et al.
J Immunother Cancer
. 2021 Mar;
9(3).
PMID: 33753569
Background: Patients with cancer are particularly susceptible to SARS-CoV-2 infection. The systemic inflammatory response is a pathogenic mechanism shared by cancer progression and COVID-19. We investigated systemic inflammation as a...
6.
Sng C, Wong Y, Wu A, Ottaviani D, Chopra N, Galazi M, et al.
Front Oncol
. 2020 Dec;
10:595804.
PMID: 33330085
Background: The COVID-19 pandemic remains a pressing concern to patients with cancer as countries enter the second peak of the pandemic and beyond. It remains unclear whether cancer and its...
7.
Pinato D, Lee A, Biello F, Segui E, Aguilar-Company J, Carbo A, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32650523
We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid study. We identified 204 cancer patients from eight...
8.
Sng C, OByrne S, Prigozhin D, Bauer M, Harvey J, Ruhle M, et al.
J Allergy Clin Immunol
. 2018 Mar;
142(1):311-314.e6.
PMID: 29522842
No abstract available.